(Q46168404)

20 December 2017

title

Beta blockers for asthma: a double-edged sword (English)

1 reference

20 December 2017

1 reference

Brian J Lipworth

1

1 reference

20 December 2017

Peter A Williamson

series ordinal

2

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

20 December 2017

number of pages

2

1 reference

inferred from page(s)

published in

The Lancet

1 reference

20 December 2017

volume

373

1 reference

20 December 2017

issue

9658

1 reference

20 December 2017

page(s)

104-105

1 reference

20 December 2017

Long-acting beta2-adrenoceptor agonists: a smart choice for asthma?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960018-0

7 January 2021

The effects of chronic dosing on the ?1 and ?2-adrenoceptor antagonism of betaxolol and atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960018-0

7 January 2021

Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960018-0

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960018-0

7 January 2021

Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960018-0

7 January 2021

Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960018-0

7 January 2021

Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960018-0

7 January 2021

The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960018-0

7 January 2021

Dose response of inhaled corticosteroids on bronchial hyperresponsiveness: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960018-0

7 January 2021

Airway-stabilizing effect of long-acting beta2-agonists as add-on therapy to inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960018-0

7 January 2021

The effects of lower than conventional doses of oral nadolol on relative beta 1/beta 2-adrenoceptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960018-0

7 January 2021

Anticholinergic blockade of beta-blocker-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960018-0

7 January 2021

10.1016/S0140-6736(09)60018-0

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

19135598

1 reference

20 December 2017